Attention AACR Annual Meeting 2018 Registrants – Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

  • Sort by:
  • Browse by:
<< first | < prev page: of 41 records per page: next > | last >>
pages: 1 2 3 4 5 6 ... 38 39 40 41 presentations: 1 to 25 of 1014
Introduction
Elaine R Mardis
Nationwide Children's Hospital, Columbus, OH, United States
from AACR Annual Meeting 2018 on April 15, 2018 9:45 AM-12:15 PM
Liquid biopsy: Novel technologies and clinical applications
Klaus Pantel
University Medical Ctr. Hamburg, Hamburg, Germany
from AACR Annual Meeting 2018 on April 15, 2018 9:45 AM-12:15 PM
Immune checkpoint therapy: From CTLA-4 to PD-1/PD-L1 and beyond
Padmanee Sharma
UT MD Anderson Cancer Ctr., Houston, TX, United States
from AACR Annual Meeting 2018 on April 15, 2018 9:45 AM-12:15 PM
Pembrolizumab versus placebo after complete resection of high-risk stage III melanoma: Efficacy and safety results from the EORTC 1325-MG/Keynote 054 double-blinded phase III trial
Alexander M Eggermont
Gustave Roussy Cancer Campus Grand Paris & University Paris-Saclay, Villejuif, France
from AACR Annual Meeting 2018 on April 15, 2018 9:45 AM-12:15 PM
Discussant
Antoni Ribas
UCLA Medical Ctr., Los Angeles, CA, United States
from AACR Annual Meeting 2018 on April 15, 2018 9:45 AM-12:15 PM
Mobilizing immunity against ovarian cancer
George Coukos
Ludwig Center for Cancer Research- University of Lausanne, Lausanne, Switzerland
from AACR Annual Meeting 2018 on April 15, 2018 9:45 AM-12:15 PM
Cancer chromosome evolution in metastases, immune evasion, adaptation and clinical outcome: Insights from the TRACERx studies
Charles Swanton
The Francis Crick Institute and UCL Cancer Institute, London, United Kingdom
from AACR Annual Meeting 2018 on April 15, 2018 9:45 AM-12:15 PM
Opportunities/Challenges for the Future
Elaine R Mardis
Nationwide Children's Hospital, Columbus, OH, United States
from AACR Annual Meeting 2018 on April 15, 2018 9:45 AM-12:15 PM
Intraoperative tumor grading through rapid lipidomic profiling with picosecond infra red laser mass spectrometry (PIRL-MS)
Arash Zarrine-Afsar
Univ. of Toronto, Toronto, ON, Canada
from AACR Annual Meeting 2018 on April 14, 2018 8:00 AM-10:00 AM
Application of mass spectrometry in CANscript: A patient-derived ex-vivo platform for biomarker discovery in cancer
Aaron J Goldman
Harvard Medical School, Cambridge, MA, United States
from AACR Annual Meeting 2018 on April 14, 2018 8:00 AM-10:00 AM
Urinary prostaglandin E2 metabolites as biomarkers in cancer
Ginger L Milne
Vanderbilt University Medical Center, Nashville, TN, United States
from AACR Annual Meeting 2018 on April 14, 2018 8:00 AM-10:00 AM
Recent advances in mass spectrometry-based oncology biomarker discovery
Ahmed M Aman
Ontario Inst. for Cancer Research, Toronto, ON, Canada
from AACR Annual Meeting 2018 on April 14, 2018 8:00 AM-10:00 AM
Targeting CDKs in thetreatment of breast cancer
Nicholas C Turner
Royal Marsden Hospital Inst. of Cancer Res., London, United Kingdom
from AACR Annual Meeting 2018 on April 14, 2018 8:00 AM-10:00 AM
Identifying clinical biomarkers for CDK4/6 inhibitors
Fabrice Andre
Institut Gustave Roussy, Villejuif, France
from AACR Annual Meeting 2018 on April 14, 2018 8:00 AM-10:00 AM
Biologic mechanisms underlying the sensitivity of ER+ cancers to CDK4/6i
Sarat Chandarlapaty
Mem. Sloan Kettering Cancer Ctr., New York, NY, United States
from AACR Annual Meeting 2018 on April 14, 2018 8:00 AM-10:00 AM
Mechanisms of intrinsic and acquired resistance to CDK4/6 inhibitors
Nikhil Wagle
Dana-Farber Cancer Institute, Newton, MA, United States
from AACR Annual Meeting 2018 on April 14, 2018 8:00 AM-10:00 AM
Highly Sensitive Tumor Detection and Classification using Methylome Analysis of Plasma cfDNA
Daniel Diniz De Carvalho
Princess Margaret Cancer Centre, Toronto, ON, Canada
from AACR Annual Meeting 2018 on April 14, 2018 10:15 AM-12:15 PM
Non-invasive detection of cancers in plasma with DNA methylation haplotypes
Kun Zhang
University of California, San Diego, La Jolla, CA, United States
from AACR Annual Meeting 2018 on April 14, 2018 10:15 AM-12:15 PM
Cancer locator: Harnessing the diagnostic potential of cell-free DNA methylation
Jasmine Xianghong Zhou
University of California at Los Angeles, Los Angeles, CA, United States
from AACR Annual Meeting 2018 on April 14, 2018 10:15 AM-12:15 PM
Epigenetic traces in plasma DNA
Michael R Speicher
Medical University of Graz, Graz, Austria
from AACR Annual Meeting 2018 on April 14, 2018 10:15 AM-12:15 PM
The role of nucleic acids in type I interferon-mediated inflammation and autoimmunity
Keith Elkon
University of Washington, Seattle, WA, United States
from AACR Annual Meeting 2018 on April 14, 2018 1:00 PM-3:00 PM
Clinical implications of disrupting the DNA damage response in cancer therapy
Kevin J Harrington
The Institute of Cancer Research, London, United Kingdom
from AACR Annual Meeting 2018 on April 14, 2018 1:00 PM-3:00 PM
Genotoxic treatment-induced DNA sensing in the context of immunotherapy
Sandra Demaria
Weill Cornell Medical College, New York, NY, United States
from AACR Annual Meeting 2018 on April 14, 2018 1:00 PM-3:00 PM
Introduction
Benjamin O. Anderson
University of Washington, Seattle, WA, United States
from AACR Annual Meeting 2018 on April 14, 2018 1:00 PM-3:00 PM
Cancer prevention and early diagnosis: Regional issues facing for Latin-America and the Caribbean
Silvana Luciani
Pan American Health Organization, Washington, DC, United States
from AACR Annual Meeting 2018 on April 14, 2018 1:00 PM-3:00 PM
<< first | < prev page: of 41 records per page: next > | last >>
pages: 1 2 3 4 5 6 ... 38 39 40 41 presentations: 1 to 25 of 1014